MenoZen VR for Menopause Symptom Management: Phase 2

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT07633743
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
45 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • MenoZen — DEVICE
    Participants will complete weekly self-administered virtual reality sessions via MenoZenVR, using a VR headset, for 8 consecutive weeks.

Study Details

The purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.

Key Dates

Start date
Jul 31, 2026
Status verified
Jun 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: MenoZen
    Menopausal women will participate in weekly virtual reality sessions using the MenoZen VR program.

Primary Outcome Measure

Change in frequency of hot flashes [ Time Frame: Baseline, 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIP
Mayo ClinicJacksonvilleFlorida32224

Find similar trials in Jacksonville, FL

By condition
Menopause
By specialty
Women's healthFertility
By research site
Mayo Clinic· Jacksonville, FL

Related Studies